Interestingly, in the murine extraskeletal tumor model, the PLCγ2-β-catenin pathway plays an important role in tumor progression, suggesting an anti-tumorigenic role for this pathway in MDSCs (40, 41). Here, PLCG2 is linked to neoplasm.